User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Litton, Jennifer K.; Hurvitz, Sara A.; Mina, Lida A.; Rugo, Hope S.; Lee, Kyung-Hun; Goncalves, Anthony; Diab, Sami; Woodward, Natasha; Goodwin, Annabel; Yerushalmi, Rinat; Roch, Henri; Im, Young-Hyuck; Eiermann, Wolfgang; Quek, Ruben G.; Usari, Tiziana; Lanzalone, Silvana; Czibere, Akos; Blum, Joanne L.; Martin, Miguel; Ettl, Johannes
Title:
Talazoparib (TALA) in germline BRCA1/2 (gBRCA1/2)-mutated human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer (ABC): Final overall survival (OS) results from randomized Phase 3 EMBRACA trial
Journal title abbreviation:
Cancer Res
Year:
2020
Journal volume:
80 Suppl S
Journal issue:
16
Fulltext / DOI:
doi:10.1158/1538-7445.AM2020-CT071
Print-ISSN:
0008-5472
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX